MENZIES SCHOOL OF HEALTH RESEARCH

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: Private

Established: 1985-01-01

Employees: 251

Market Cap: -

Website: https://www.menzies.edu.au

Clinical Trials

Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated Malaria

Completed

Conditions: Plasmodium Vivax Infection
Plasmodium Falciparum Infection

First Posted Date: 2015-02-02

Last Posted Date: 2017-02-01

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 130

Registration Number: NCT02353494

Locations: 🇮🇩
Timika District Hospital, Timika, Indonesia

Artemether-lumefantrine vs Chloroquine for Uncomplicated P. Vivax Malaria in Malaysia

Phase 3

Conditions: Plasmodium Vivax Malaria Without Complication

Interventions: Drug: Artemether-lumefantrine + Primaquine
Drug: Chloroquine + Primaquine

First Posted Date: 2015-01-28

Last Posted Date: 2017-02-01

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 98

Registration Number: NCT02348788

Locations: 🇲🇾
Pitas District Hospital, Pitas, Sabah, Malaysia
🇲🇾
Kudat District Hospital, Kudat, Sabah, Malaysia
🇲🇾
Kota Marudu District Hospital, Kota Marudu, Sabah, Malaysia

P. Knowlesi Trial of Artemether-lumefantrine vs Chloroquine

Phase 3

Completed

Conditions: Uncomplicated Knowlesi Malaria

Interventions: Drug: Chloroquine
Drug: Artemether-lumefantrine combination

First Posted Date: 2013-12-04

Last Posted Date: 2017-07-07

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 123

Registration Number: NCT02001012

Locations: 🇲🇾
Pitas District Hospital, Pitas, Sabah, Malaysia
🇲🇾
Kota Marudu District Hospital, Kota Marudu, Sabah, Malaysia
🇲🇾
Kudat District Hospital, Kudat, Sabah, Malaysia

Safety and Efficacy of Primaquine for P. Vivax

Not Applicable

Conditions: Malaria

Interventions: Drug: Primaquine
Drug: delayed primaquine

First Posted Date: 2013-04-23

Last Posted Date: 2013-11-08

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 180

Registration Number: NCT01837992

Locations: 🇻🇺
Northern Provincial Hospital, Nambauk Aid Post, V.F.H.A Dispensary and Fanafo Dispensary, Luganville, Sanma Province, Vanuatu
🇻🇺
Toroa Dispensary, NTM Health Centre and Vila Central Hospital, Port Vila, Shefa Province, Vanuatu
🇸🇧
Tetere Hospital, Guadalcanal Province, Honiara, Guadalcanal Province, Solomon Islands

and more 1 locations

Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life

Phase 4

Completed

Conditions: Otitis Media
Febrile Illness
Lower Respiratory Tract Infection
Cough
Upper Respiratory Tract Infection

Interventions: Biological: Synflorix
Biological: Prevenar13

First Posted Date: 2012-11-28

Last Posted Date: 2020-03-25

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 261

Registration Number: NCT01735084

Locations: 🇦🇺
Menzies School of Health Research, Darwin, Northern Territory, Australia

Safety and Efficacy of Chloroquine and Primaquine for Vivax Malaria in Bhutan

Completed

Conditions: Vivax Malaria

Interventions: Drug: Chloroquine
Drug: Primaquine

First Posted Date: 2012-10-29

Last Posted Date: 2016-05-27

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 24

Registration Number: NCT01716260

Locations: 🇧🇹
Vector Diseases Control Program, Gelephu, Bhutan

P. Knowlesi Trial of Artesunate-mefloquine Versus Chloroquine

Phase 3

Completed

Conditions: Uncomplicated Plasmodium Knowlesi Malaria

Interventions: Drug: Artesunate-mefloquine
Drug: Chloroquine
Drug: Primaquine

First Posted Date: 2012-10-17

Last Posted Date: 2015-04-09

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 250

Registration Number: NCT01708876

Locations: 🇲🇾
Kudat District Hospital, Kudat, Sabah, Malaysia
🇲🇾
Kota Marudu District Hospital, Kota Marudu, Sabah, Malaysia
🇲🇾
Pitas District Hospital, Pitas, Sabah, Malaysia

Pneumococcal Vaccines Early and in Combination

Phase 4

Completed

Conditions: Otitis Media

Interventions: Drug: Synflorix
Drug: Prevenar13
Drug: COMBO

First Posted Date: 2010-08-04

Last Posted Date: 2018-10-18

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 425

Registration Number: NCT01174849

Locations: 🇦🇺
Menzies School of Health Research, Darwin, Northern Territory, Australia

Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory

Completed

Conditions: Scabies
Streptococcal Infections
Impetigo
Pyoderma

First Posted Date: 2009-04-21

Last Posted Date: 2009-04-21

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 2329

Registration Number: NCT00884728

Locations: 🇦🇺
Menzies School of Health Research, Casuarina, Northern Territory, Australia

PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers

Phase 3

Completed

Conditions: Acute Otitis Media
Tympanic Membrane Perforation
Pneumococcal Infections
Middle Ear Effusion

Interventions: Biological: 23vPPV, dTpa (Pneumovax, Boostrix)

First Posted Date: 2008-07-14

Last Posted Date: 2014-07-10

Lead Sponsor: Menzies School of Health Research

Target Recruit Count: 227

Registration Number: NCT00714064

Locations: 🇦🇺
Menzies School of Health Research, Darwin, Northern Territory, Australia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy